Majumder S, Chakraborty A K, Mandal T K, Bhattacharya A, Basak D K
Department of Pharmacology and Toxicology, Bidhan Chandra Krishi Viswavidyalaya, Dist. Nadia, India.
Indian J Exp Biol. 1994 Oct;32(10):752-6.
Subacute toxicity study of fenvalerate was carried out in broiler chicks after oral administration @ 525.6 mg/kg once daily for 28 days. The blood concentration of fenvalerate following 1 day post-administration (pd) was 39.65 +/- 2.67 micrograms/ml and maintained plateau thereafter up to day 21 pd, and then declined (18.46 +/- 1.47 micrograms/ml) on day 28 pd. Intestine contained maximum residue (7.46 +/- 1.96 micrograms/g) followed by fat (5.95 +/- 1.16 micrograms/g), brain (5.06 +/- 0.96 micrograms/g), liver (3.93 +/- 0.51 micrograms/g), kidney (3.79 +/- 0.72 micrograms/g) and heart (1.72 +/- 0.35 micrograms/g). Histopathological examinations showed focal areas of necrosis in liver, proliferation and fibrosis of bile duct, larger size of glomeruli, glomerular and tubular necrosis in treated birds. Fenvalerate significantly increased the cholesterol level in brain, GPT activity in liver and heart, GOT activity in heart, and alkaline phosphatase activity in heart and brain tissue. It significantly decreased the glycogen content in liver and heart, GOT activity in brain and acid phosphatase activity in all the tissues analyzed. It appears that comparatively fowl is resistant to fenvalerate toxicity.
对肉鸡进行了氰戊菊酯的亚急性毒性研究,以525.6毫克/千克的剂量每日口服一次,持续28天。给药后1天(pd)氰戊菊酯的血药浓度为39.65±2.67微克/毫升,此后直至给药后第21天保持稳定,然后在给药后第28天下降(18.46±1.47微克/毫升)。肠道中残留量最高(7.46±1.96微克/克),其次是脂肪(5.95±1.16微克/克)、脑(5.06±0.96微克/克)、肝(3.93±0.51微克/克)、肾(3.79±0.72微克/克)和心脏(1.72±0.35微克/克)。组织病理学检查显示,受试鸡肝脏有局灶性坏死区域、胆管增生和纤维化、肾小球体积增大、肾小球和肾小管坏死。氰戊菊酯显著提高了脑中胆固醇水平、肝脏和心脏中的GPT活性、心脏中的GOT活性以及心脏和脑组织中的碱性磷酸酶活性。它显著降低了肝脏和心脏中的糖原含量、脑中的GOT活性以及所有分析组织中的酸性磷酸酶活性。看来禽类对氰戊菊酯毒性具有相对抗性。